Product

Popular information

Antitumor drugs Bortezomib 179324-69-7

【Alias】 [(1R) -3-methyl-1-[[((2S) -1-oxo-3-phenyl-2-[(pyrazinyl) amino] propyl] amino] butyl] -boronic acid; Patzomi
【Catalog number】AP0100
【CAS #】 179324-69-7
【Molecular formula】 C19H25BN4O4
【Product Brief】US-DMF No. 22884 Bortezomib, the English name is Bortezomib, and the American Chemical Abstracts Registration Number is cas179324-69-7.
English Name : Bortezomib
CAS# : 179324-69-7
产品描述
[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[产品参数, 参数]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]

 

Antitumor drugs

Bortezomib
CAS 179324-69-7
US-DMF No. 22884

Alias [(1R) -3-methyl-1-[[((2S) -1-oxo-3-phenyl-2-[(pyrazinyl) amino] propyl] amino] butyl] -boronic acid; Patzomi

Catalog number AP0100

CAS # 179324-69-7

Molecular formula C19H25BN4O4

Molecular weight 384.24

Structural formula

威智医药

Product introduction

CAS 179324-69-7

US-DMF No. 22884 Bortezomib, the English name is Bortezomib, and the American Chemical Abstracts Registration Number is cas179324-69-7.

Bortezomib (cas 179324-69-7) is a reversible inhibitor of 26S proteasome chymotrypsin-like activity in mammalian cells. In vitro tests have proven that bortezomib is cytotoxic to many types of cancer cells. Preclinical tumor model in vivo tests have demonstrated that bortezomib can delay tumor growth, including multiple myeloma. This product is used for the treatment of patients with multiple myeloma, and its effectiveness is based on its effectiveness.

扫二维码用手机看
未找到相应参数组,请于后台属性模板中添加
search
Confirm
Close